A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin
Clinical trial NCT06767761 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06767761
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-18
- Primary completion
- 2026-03-19
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.